The neutral cysteine protease bleomycin hydrolase is essential for epidermal integrity and bleomycin resistance

The papain superfamily member bleomycin hydrolase (Blmh) is a neutral cysteine protease with structural similarity to a 20S proteasome. Bleomycin (BLM), a clinically used glycopeptide anticancer agent, is deaminated in vitro by Blmh. We used gene targeting to generate mice that lack Blmh and demonst...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 96; no. 8; pp. 4680 - 4685
Main Authors Schwartz, D R, Homanics, G E, Hoyt, D G, Klein, E, Abernethy, J, Lazo, J S
Format Journal Article
LanguageEnglish
Published United States National Acad Sciences 13.04.1999
National Academy of Sciences
The National Academy of Sciences
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The papain superfamily member bleomycin hydrolase (Blmh) is a neutral cysteine protease with structural similarity to a 20S proteasome. Bleomycin (BLM), a clinically used glycopeptide anticancer agent, is deaminated in vitro by Blmh. We used gene targeting to generate mice that lack Blmh and demonstrated that Blmh is the sole enzyme required for BLM deamination. Although some Blmh null mice were viable and reproduced, only about 65% of the expected number survived the neonatal period, revealing an important role for Blmh in neonatal survival. Mice lacking Blmh exhibited variably penetrant tail dermatitis that resembled rodent ringtail. The histopathology of the tail dermatitis was similar to skin lesions in humans with pellagra, necrolytic migratory erythema, and acrodermatitis enteropathica. Compared with controls, Blmh null mice were more sensitive to acute BLM lethality and developed pulmonary fibrosis more readily following BLM treatment. Thus, we have established that Blmh is an essential protectant against BLM-induced death and has an important role in neonatal survival and in maintaining epidermal integrity.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
Present address: College of Pharmacy, Ohio State University, Columbus, OH 43210.
To whom reprint requests should be addressed at: Department of Pharmacology, University of Pittsburgh, Biomedical Science Tower E1340, Pittsburgh, PA 15261. e-mail: lazo@pop.pitt.edu.
Communicated by Mary Edmonds, University of Pittburgh, Pittsburgh, PA
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.96.8.4680